1. Controlling nutritional status (CONUT) score-based nomogram to predict overall survival of patients with pancreatic cancer undergoing radical surgery
- Author
-
Renyi Qin, Feng Zhu, Min Wang, Chao Dang, and Tingting Qin
- Subjects
Oncology ,medicine.medical_specialty ,Multivariate analysis ,business.industry ,Nutritional Status ,Cancer ,Nutritional status ,Ajcc stage ,Nomogram ,Prognosis ,medicine.disease ,Pancreatic Neoplasms ,Nomograms ,Internal medicine ,Pancreatic cancer ,medicine ,Overall survival ,Humans ,Surgery ,Radical surgery ,business ,Biomarkers ,Retrospective Studies - Abstract
Summary Background /Objective: As a new immune-nutritional marker, the controlled nutritional status (CONUT) score has been reported to predict the prognosis of cancer patients. We aimed to elucidate the prognostic value of preoperative CONUT score in pancreatic cancer patients undergoing radical surgery, and to construct a nomogram based on CONUT score to predict individual survival. Methods Preoperative CONUT scores were calculated prospectively in 382 patients with pancreatic cancer who underwent radical surgery. Evaluated the relationship between CONUT score and pancreatic cancer prognosis. Cox proportional hazard models were used to determine predictors of survival and a new nomogram was established to predict pancreatic cancer overall survival (OS). Results The area under curve of CONUT score was higher than other immune-nutritional indexes. The OS of the high-CONUT group were significantly lower than that of low-CONUT group. Multivariate analysis showed that CONUT score, gender, AJCC stage, complications and reoperation were independent prognostic factors for OS. Nomogram based on these variables has better discriminant ability in predicting survival compared with other traditional staging systems. Conclusions Preoperative CONUT score is an effective independent predictor of OS in pancreatic cancer patients undergoing radical surgery. This new CONUT based nomogram provides accurate, individualized survival prediction for pancreatic cancer.
- Published
- 2022
- Full Text
- View/download PDF